Whalesbook
Chalo, toh ab scene yeh hai ki jo desh bhar mein dukaan band karne ka plan tha na pharmacies ka, woh May 20 ko nahi hoga. Major pharma associations ne kaha ki woh strike par nahi jayenge. Ye sab isliye hua kyunki Central Drugs Standard Control Organisation (CDSCO) ne unhe bharosa dilaya hai ki woh e-pharmacy sector ko lekar jo concerns hain, unhe seriously review karenge. Abhi immediate strike se zyada focus regulations ki baatein karne par hoga.
Retailers ke liye sabse badi tension thi e-pharmacies ki badhti hui popularity. Unhone CDSCO ko bataya hai ki market mein competition, data privacy aur online davaaiyo ki reliability jaise issues hain. Isliye, CDSCO abhi jo current rules hain, unko dekhega taaki digital health services ka growth aur existing physical pharmacies ka balance bana rahe.
Aur ek achhi baat yeh hai ki almost sabhi states ke pharmacy associations ne strike se peeche hatne ka decision liya hai. West Bengal, Kerala, Punjab, Maharashtra, Gujarat, UP, Haryana jaise states ne officially confirm kiya hai ki dawaaiyo ki availability maintain rakhi jayegi. Ye sab regulator ke positive response aur public interest ko dhyan mein rakhte hue hua hai.
Vese toh India mein e-pharmacy market bahut fast grow kar raha hai. Log convenience, better prices aur wide reach ki wajah se Netmeds aur PharmEasy jaise platforms use kar rahe hain. Is digital shift ne traditional dukaanon par kaafi pressure daala hai, jahan prices match karna mushkil ho raha hai. CDSCO ka ye review bahut important hai, kyunki naye rules online aur offline dono ke operations ko affect kar sakte hain.
Abhi strike cancel ho gayi ho, par dono taraf ki tensions abhi bhi hain. CDSCO ke review se e-pharmacies ke liye naye compliance rules aa sakte hain, jisse unka growth slow ho sakta hai ya cost badh sakti hai. Agar regulations e-pharmacies ke favour mein gaye, toh choti dukaanon ke profit margins aur kam ho sakte hain. AIOCD ne warned bhi kiya hai ki isse kuch dukaanen band bhi ho sakti hain. Ek aur tension yeh hai ki regulatory action mein der na ho jaye, jisse sab log uncertainty mein rahenge. National Digital Health Mission bhi ismein aur complexities la sakta hai.
Ab sabki nazar CDSCO ke review process par hai. Koi formal timeline nahi batayi gayi hai, par ye examination chal raha hai. Iska result shayad e-pharmacy operations ke liye updated guidelines layega, jo India ke pharma retail industry mein investment aur market consolidation ko influence kar sakta hai. Analysts ka kehna hai ki healthcare ab irreversibly online ho raha hai, but sustainable growth ke liye ek balanced regulatory environment zaroori hai, jo innovation aur public safety dono ko protect kare.